Mabwell (shanghai) Bioscience Co., Ltd. Class ASSE: 688062

Announcement on the Results of Issuance of the 2026 Phase I Targeted Science and Technology Innovation Bonds

· Issued by Mabwell (shanghai) Bioscience Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Results of Issuance of the 2026 Phase I Targeted Science and Technology Innovation Bonds

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment